BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Българска асоциация по патология - ECPv5.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Българска асоциация по патология
X-ORIGINAL-URL:https://bpa-pathology.com
X-WR-CALDESC:Събития за Българска асоциация по патология
BEGIN:VTIMEZONE
TZID:Europe/Sofia
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Sofia:20240921T080000
DTEND;TZID=Europe/Sofia:20240926T170000
DTSTAMP:20260425T181232
CREATED:20230717T115656Z
LAST-MODIFIED:20230717T115656Z
UID:3649-1726905600-1727370000@bpa-pathology.com
SUMMARY:22nd Meeting of the European Association for Hematopathology
DESCRIPTION:TOPIC: NOVEL MECHANISMS IN LYMPHOMAGENESIS \nDubrovnik\, Croatia | 21- 26 September 2024 \nThe past meeting was a great experience and a huge success for our society. \nThe next meeting will take place at the Congress Centre of Valamar Lacroma hotel in Dubrovnik\, located approximately 4 km from Dubrovnik Old Town. We are preparing an exciting social program including the Networking dinner at the Copacabana beach near the congress venue\, so don’t miss it! \nThe board worked intensively to delineate a timely and interesting scientific program for the 2024 meeting. \nThe overarching theme of the Dubrovnik 2024 lymphoma symposium will be “Novel Mechanisms in Lymphomagenesis”\, with the following 5 sessions: \n1) Clonal lymphoid hematopoiesis \n2) Epigenetics in lymphomagenesis \n3) Lymphoproliferations associated with germline abnormalities \n4) New frontiers in lymphoma treatment \n5) Recent advances session\, including a keynote lecture that will deal with “artificial intelligence\nand lymphoma diagnosis”
URL:https://bpa-pathology.com/event/22nd-meeting-of-the-european-association-for-hematopathology/
LOCATION:Valamar Lacroma Dubrovnik Hotel\, Dubrovnik\, Dubrovnik\, Хърватия
END:VEVENT
END:VCALENDAR